Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Snakebite envenomation causes over 140,000 deaths every year, predominantly in developing countries. As a result, it is one of the most lethal neglected tropical diseases. It is associated with incredibly complex pathophysiology due to the vast number of unique toxins/proteins present in the venoms of diverse snake species found worldwide. Here, we report the purification and functional characteristics of a Group I (PI) metalloprotease (CAMP-2) from the venom of the western diamondback rattlesnake, Crotalus atrox. Its sensitivity to matrix metalloprotease inhibitors (batimastat and marimastat) was established using specific in vitro experiments and in silico molecular docking analysis. CAMP-2 shows high sequence homology to atroxase from the venom of Crotalus atrox and exhibits collagenolytic, fibrinogenolytic and mild haemolytic activities. It exerts a mild inhibitory effect on agonist-induced platelet aggregation in the absence of plasma proteins. Its collagenolytic activity is completely inhibited by batimastat and marimastat. Zinc chloride also inhibits the collagenolytic activity of CAMP-2 by around 75% at 50 μM, while it is partially potentiated by calcium chloride. Molecular docking studies have demonstrated that batimastat and marimastat are able to bind strongly to the active site residues of CAMP-2. This study demonstrates the impact of matrix metalloprotease inhibitors in the modulation of a purified, Group I metalloprotease activities in comparison to the whole venom. By improving our understanding of snake venom metalloproteases and their sensitivity to small molecule inhibitors, we can begin to develop novel and improved treatment strategies for snakebites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies have examined the effects of various small molecule inhibitors on the biological activities of venoms in vitro and the neutralization capacity of these inhibitors in vivo (49, 50, 51, 53, 56, 57, 58, 59).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [51]
In the citing paper
“A repurposed low-specificity matrix metalloprotease inhibitor, marimastat, has shown effective neutralization of SVMP-rich venoms across multiple venomous snake species by preventing both local and systemic toxicity (53), decreasing hemotoxic venom effects (50, 51, 53, 60, 61), reducing SVMP-induced cytotoxicity (56, 60), and inhibiting extracellular matrix degradation (62).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [51]
In the citing paper
“A previous study performed molecular docking analysis using marimastat and a purified PI SVMP proteoform CAMP-2 to demonstrate a direct interaction (51).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [51]
In the citing paper
“Research on small molecule inhibitors of snake venom toxins has typically focused on in vitro and in vivo functional assays based on the known or likely biological activities of toxins (49, 50, 51, 52, 53, 58, 109, 110, 111, 112, 113).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [51]
In the citing paper
“PISA assays were performed on marimastat, an inhibitor of matrix metalloproteases that has shown significant inhibitory activity against SVMPs (50, 51, 53, 56, 60, 61, 62).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fox, J. W., & Serrano, S. M. T. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.02.012 · Cited by 587 · cited 1×
“SVMPs are classified into PI to PIV depending on the presence of additional domains [15]: PI—only a metalloprotease domain; PII—a metalloprotease and a disintegrin domain; PIII—a metalloprotease domain, a disintegrin-like and a cysteine-rich domain; PIV—two C-type lectin domains in addition to all the domains present…”
Background
Research works printed but not linked: 41
- Gutierrez, 2017, Snakebite envenoming, Nat. Rev. Dis. Primers, 3, 17079, 10.1038/nrdp.2017.79 · DOI · Paper page
- Chippaux, 2017, Snakebite envenomation turns again into a neglected tropical disease!, J. Venom. Anim. Toxins Incl. Trop. Dis., 23, 38, 10.1186/s40409-017-0127-6 · DOI · Paper page
- Kasturiratne, A., Wickremasinghe, A.R., de Silva, N., Gunawardena, N.K., Pathmeswaran, A., Premaratna, R., Savioli, L., Lalloo, D.G., and de Silva, H.J. (2008). The global burden of snakebite: A literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med., 5. · DOI · Paper page
- Williams, 2010, The Global Snake Bite Initiative: An antidote for snake bite, Lancet, 375, 89, 10.1016/S0140-6736(09)61159-4 · DOI · Paper page
- Williams, H.F., Layfield, H.J., Vallance, T., Patel, K., Bicknell, A.B., Trim, S.A., and Vaiyapuri, S. (2019). The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites. Toxins (Basel), 11. · DOI
- Sunagar, 2014, Intraspecific venom variation in the medically significant Southern Pacific Rattlesnake (Crotalus oreganus helleri): Biodiscovery, clinical and evolutionary implications, J. Proteom., 99, 68, 10.1016/j.jprot.2014.01.013 · DOI
- Fry, 2003, Effectiveness of Snake Antivenom: Species and Regional Venom Variation and Its Clinical Impact, J. Toxicol. Toxin Rev., 22, 23, 10.1081/TXR-120019018 · DOI
- Pla, 2017, Proteomic analysis of venom variability and ontogeny across the arboreal palm-pitvipers (genus Bothriechis), J. Proteom., 152, 1, 10.1016/j.jprot.2016.10.006 · doi:10.1016/j.jprot.2016.10.006
- Modahl, 2016, An analysis of venom ontogeny and prey-specific toxicity in the Monocled Cobra (Naja kaouthia), Toxicon, 119, 8, 10.1016/j.toxicon.2016.04.049 · DOI
- Harrison, R.A., Hargreaves, A., Wagstaff, S.C., Faragher, B., and Lalloo, D.G. (2009). Snake envenoming: A disease of poverty. PLoS Negl. Trop. Dis., 3. · DOI · Paper page
- Yanez-Arenas, C., Peterson, A.T., Mokondoko, P., Rojas-Soto, O., and Martinez-Meyer, E. (2014). The use of ecological niche modeling to infer potential risk areas of snakebite in the Mexican state of Veracruz. PLoS ONE, 9. · DOI
- Calvete, 2009, Exploring the venom proteome of the western diamondback rattlesnake, Crotalus atrox, via snake venomics and combinatorial peptide ligand library approaches, J. Proteome Res., 8, 3055, 10.1021/pr900249q · DOI · Paper page
- Gutierrez, 2000, Snake venom metalloproteinases: Their role in the pathogenesis of local tissue damage, Biochimie, 82, 841, 10.1016/S0300-9084(00)01163-9 · DOI · Paper page
- Williams, H.F., Mellows, B.A., Mitchell, R., Sfyri, P., Layfield, H.J., Salamah, M., Vaiyapuri, R., Collins-Hooper, H., Bicknell, A.B., and Matsakas, A. (2019). Mechanisms underpinning the permanent muscle damage induced by snake venom metalloprotease. PLoS Negl. Trop. Dis., 13. · DOI
- Rasmussen, 1997, Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat, Pharm. Ther., 75, 69, 10.1016/S0163-7258(97)00023-5 · DOI · Paper page
- Knudsen, C., and Laustsen, A.H. (2018). Recent Advances in Next Generation Snakebite Antivenoms. Trop. Med. Infect. Dis., 3. · DOI
- Markland, 2013, Snake venom metalloproteinases, Toxicon, 62, 3, 10.1016/j.toxicon.2012.09.004 · DOI · Paper page
- Baker, 1995, Nucleotide sequence encoding the snake venom fibrinolytic enzyme atroxase obtained from a Crotalus atrox venom gland cDNA library, Arch. Biochem. Biophys., 317, 357, 10.1006/abbi.1995.1175 · doi:10.1006/abbi.1995.1175
- Willis, 1988, Purification and biochemical characterization of atroxase, a nonhemorrhagic fibrinolytic protease from western diamondback rattlesnake venom, Biochemistry, 27, 4769, 10.1021/bi00413a028 · DOI
- Tu, 1996, Biochemical characterization of atroxase and nucleotide sequence encoding the fibrinolytic enzyme, Toxicon, 34, 1295, 10.1016/S0041-0101(96)00106-7 · doi:10.1016/s0041-0101(96)00106-7
- Baker, 1996, Atroxase—A fibrinolytic enzyme isolated from the venom of western diamondback rattlesnake. Isolation, characterization and cloning, Adv. Exp. Med. Biol., 391, 203, 10.1007/978-1-4613-0361-9_13 · doi:10.1007/978-1-4613-0361-9_13
- Willis, 1989, Thrombolysis with a snake venom protease in a rat model of venous thrombosis, Thromb. Res., 53, 19, 10.1016/0049-3848(89)90112-6 · doi:10.1016/0049-3848(89)90112-6
- Waterhouse, 2018, SWISS-MODEL: Homology modelling of protein structures and complexes, Nucleic Acids Res., 46, W296, 10.1093/nar/gky427 · DOI · Paper page
- Morris, 2008, Using AutoDock for ligand-receptor docking, Curr. Protoc. Bioinform., 24, 8.14.1, 10.1002/0471250953.bi0814s24 · DOI · Paper page
- Vaiyapuri, S., Vaiyapuri, R., Ashokan, R., Ramasamy, K., Nattamaisundar, K., Jeyaraj, A., Chandran, V., Gajjeraman, P., Baksh, M.F., and Gibbins, J.M. (2013). Snakebite and its socio-economic impact on the rural population of Tamil Nadu, India. PLoS ONE, 8. · DOI · Paper page
- Williams, 2017, Challenges in diagnosing and treating snakebites in a rural population of Tamil Nadu, India: The views of clinicians, Toxicon, 130, 44, 10.1016/j.toxicon.2017.02.025 · doi:10.1016/j.toxicon.2017.02.025
- Winer, 2018, Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes, Mol. Cancer Ther., 17, 1147, 10.1158/1535-7163.MCT-17-0646 · DOI · Paper page
- Vandenbroucke, 2014, Is there new hope for therapeutic matrix metalloproteinase inhibition?, Nat. Rev. Drug Discov., 13, 904, 10.1038/nrd4390 · DOI · Paper page
- Vaiyapuri, 2012, Rhinocetin, a venom-derived integrin-specific antagonist inhibits collagen-induced platelet and endothelial cell functions, J. Biol. Chem., 287, 26235, 10.1074/jbc.M112.381483 · DOI
- Howes, 2007, Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators, Toxicon, 49, 734, 10.1016/j.toxicon.2006.11.020 · DOI
- Teicher, B.A. (1999). Batimastat and Marimastat in Cancer. Antiangiogenic Agents in Cancer Therapy, Humana Press. · DOI · Paper page
- Rucavado, 2004, Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: Understanding the role of metalloproteinases in envenomation, Toxicon, 43, 417, 10.1016/j.toxicon.2004.01.016 · DOI
- Rucavado, 2000, Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: Effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA, Am. J. Trop. Med. Hyg., 63, 313, 10.4269/ajtmh.2000.63.313 · DOI · Paper page
- Escalante, 2000, Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper, Biochem. Pharm., 60, 269, 10.1016/S0006-2952(00)00302-6 · DOI
- Ainsworth, 2018, The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms, Commun. Biol., 1, 34, 10.1038/s42003-018-0039-1 · DOI
- Cordeiro, 2018, Purification and enzymatic characterization of a novel metalloprotease from Lachesis muta rhombeata snake venom, J. Venom. Anim. Toxins Incl. Trop. Dis., 24, 32, 10.1186/s40409-018-0171-x · doi:10.1186/s40409-018-0171-x
- Huber, 1997, Inhibition of carboxypeptidase A by excess zinc: Analysis of the structural determinants by X-ray crystallography, Febs Press, 400, 336, 10.1016/S0014-5793(96)01412-3 · DOI
- Takeda, S. (2016). ADAM and ADAMTS Family Proteins and Snake, Venom Metalloproteinases: A Structural Overview. Toxins, 8. · DOI · Paper page
- Kini, R.M., and Koh, C.Y. (2016). Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites. Toxins (Basel), 8. · DOI · Paper page
- Yamazaki, 2007, Snake venom components affecting blood coagulation and the vascular system: Structural similarities and marked diversity, Curr. Pharm. Des., 13, 2872, 10.2174/138161207782023775 · DOI · Paper page
- Vaiyapuri, 2015, EphB2 regulates contact-dependent and contact-independent signaling to control platelet function, Blood, 125, 720, 10.1182/blood-2014-06-585083 · DOI
Cited by
Causes and Consequences of Snake Venom Variation
Casewell, N. R., Jackson, T. N. W., Laustsen, A. H., & Sunagar, K. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.05.006 · Cited by 396
Hall, S. R., Rasmussen, S. A., Crittenden, E., Dawson, C. A., Bartlett, K. E., Westhorpe, A. P., Albulescu, L.-O., Kool, J., Gutiérrez, J. M., & Casewell, N. R. (2023) · Nature Communications · doi:10.1038/s41467-023-43510-w · Cited by 63
Smith, C. F., Modahl, C. M., Ceja Galindo, D., Larson, K. Y., Maroney, S. P., Bahrabadi, L., Brandehoff, N. P., Perry, B. W., McCabe, M. C., Petras, D., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100779 · Cited by 11
Metadata
- Authors
- Layfield, H. J., Williams, H. F., Ravishankar, D., Mehmi, A., Sonavane, M., Salim, A., Vaiyapuri, R., Lakshminarayanan, K., Vallance, T. M., Bicknell, A. B., Trim, S. A., Patel, K., & Vaiyapuri, S.
- Affiliations
- School of Pharmacy, University of Reading, Reading RG6 6UB, UK
- Toxiven Biotech Private Limited, Coimbatore, Tamil Nadu 641042, India
- School of Biological Sciences, University of Reading, Reading RG6 6UB, UK
- Venomtech Limited, Sandwich, Kent CT13 9ND, UK
- Venue
- Toxins
- Publisher
- MDPI AG
- Published
- 2020-05-09
- Volume
- 12
- Issue
- 5
- Pages
- 309
- ISSN
- 2072-6651
- Cited by
- 48
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox. https://app.cochat.ai/papers/10.3390/toxins12050309
- The paper
- Layfield, H. J., Williams, H. F., Ravishankar, D., Mehmi, A., Sonavane, M., Salim, A., Vaiyapuri, R., Lakshminarayanan, K., Vallance, T. M., Bicknell, A. B., Trim, S. A., Patel, K., & Vaiyapuri, S. (2020). Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox. Toxins. https://doi.org/10.3390/toxins12050309
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.